Simon Mallal
Director, Vanderbilt Center for Translational and Clinical Immunology · Vanderbilt University Medical Center
Credentials: · ·
History
- Present
Vanderbilt Center for Translational and Clinical Immunology · Vanderbilt University Medical Center
- 1983–1986
Internal Medicine
Research
HLA-B*5701 screening for hypersensitivity to abacavir
New England Journal of Medicine · 2008 · First of 19 authors · Corresponding · 1,315 citations
A whole-genome association study of major determinants for host control of HIV-1
Science · 2007 · 1,016 citations
The Lancet · 2002 · First of 12 authors · Corresponding · 1,010 citations
107 papers
29 papers · 3 as a fellow
27 papers
- BW
21 papers
19 papers
- MP
19 papers
- SB
18 papers · 6 as a fellow
14 papers · 3 as a fellow
Grants
- 2023–2030
ECHO Laboratory Core at Vanderbilt for Integrated Sample Biobanking and Processing
NIH Office of the Director · U24
PI · $32.8M · Vanderbilt University Medical Center
- 1997–2027
National Cancer Institute · P30
Project lead · $3.8M · Vanderbilt University Medical Center
- 2015–2025
Tennessee CFAR: 2027 National Program Meeting
National Institute of Allergy and Infectious Diseases · P30
Contact PI · $18.4M · Vanderbilt University Medical Center
- 2004–2010
HIV-1 Adaptation to HLA-Restricted Immune Responses
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.3M · Murdoch University